Drug Trial Radar · NCT03667690
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Last checked: Nov 19, 2026Latest source record: Jan 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
199
Actual
Start
Oct 7, 2018
Primary completion
Oct 7, 2021
Study completion Oct 7, 2021
Sponsor
- Lead sponsor
- Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Industry
- Sponsor type
- Industry
- First posted
- Sep 12, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this pivotal study is to determine if intravenous Rezafungin is efficacious and safe in the treatment of candidemia and/or invasive candidiasis when compared to caspofungin (followed by optional oral fluconazole).
Conditions
- Candidemia
- Mycoses
- Fungal Infection
- Invasive Candidiases
Interventions
Rezafungin for InjectionDrug
Intravenous antifungal therapy
CaspofunginDrug
Intravenous antifungal therapy
FluconazoleDrug
Oral antifungal therapy
intravenous placeboDrug
Normal saline
oral placeboDrug
Microcrystalline cellulose
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-Cause Mortality (US FDA Only)Time frame: Day 30 (-2 days)
- Global Response as Assessed by Data Review Committee (EU European Medicines Agency [EMA] Only)Time frame: Day 14 (±1 day)
Locations
132 sites in 18 countries. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
UC Davis
Sacramento, California
Emory University Hospital
Atlanta, Georgia
Augusta University
Augusta, Georgia
Johns Hopkins
Baltimore, Maryland
Henry Ford Health System
Detroit, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic Hospital-Rochester
Rochester, Minnesota
University of Mississippi Medical Center
Jackson, Mississippi
Washington University St. Louis
St Louis, Missouri
Mecury Street Medical
Butte, Montana
University of North Carolina
Chapel Hill, North Carolina
Duke University Medical Center
Durham, North Carolina
ID Clinical Research, Ltd.
Toledo, Ohio
University of Pittsburgh Falk Medical Center
Pittsburgh, Pennsylvania
Reading Hospital and Medical Center
West Reading, Pennsylvania
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
Baylor Scott and White Medical Center
Temple, Texas
Carilion Clinic
Roanoke, Virginia
Alexander Fleming Specialized Medical Institute
Buenos Aires, Argentina
Cordoba Private Hospital
Córdoba, Argentina
Allende Sanatorium
Córdoba, Argentina
Mayo Private Sanatorium
Córdoba, Argentina
Italian Hospital of Mendoza
Mendoza, Argentina
Westmead Public Hospital
Northmead, New South Wales, Australia
Monash Health
Clayton, Victoria, Australia
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Alfred Health
Melbourne, Victoria, Australia
Royal Melbourne Hospital (RMH)
Parkville, Victoria, Australia
Brugmann University Hospital Center
Brussels, Belgium
Erasme Hospital
Brussels, Belgium
University Hospital Brussels
Brussels, Belgium
Saint Luc University Hospital
Brussels, Belgium
University Hospitals Leuven, Campus Gasthuisberg
Leuven, Belgium
Multiprofile Hospital for Active Treatment Puls
Blagoevgrad, Bulgaria
University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov EAD, Sofia, Clinic of Purulent-Septic Surgery
Sofia, Bulgaria
University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov EAD
Sofia, Bulgaria
Huashan Hospital Affiliated Fudan University
Shanghai, China
Shanghai Pulmonary Hospital
Shanghai, China
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
Showing 40 of 132 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.